Publications by authors named "Mark Busbridge"

Claim this Profile
P
Predictors of iron versus erythropoietin responsiveness in anemic hemodialysis patients.
Sarah Hildebrand, Mark Busbridge, Neill D Duncan, Frederick W K Tam, Damien R Ashby

Hemodial Int· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Effects of Kisspeptin Administration on Bone Metabolism in Healthy Men.
Alexander N Comninos, Morten S Hansen, Alan Courtney, Sirazum Choudhury, Lisa Yang, Mark Busbridge

J Clin Endocrinol Metab· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepcidin secretion was not directly proportional to intracellular iron-loading in recombinant-TfR1 HepG2 cells: short communication.
Kosha J Mehta, Mark Busbridge, Vinood B Patel, Sebastien Je Farnaud

Mol Cell Biochem· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepcidin clearance is associated with erythropoietin requirement in stable hemodialysis patients
.
Damien Ashby, Mark Busbridge, Sarah Hildebrand, Candice Clarke, Georgina Aldous

Clin Nephrol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Iron Treatments Aggravate Epistaxis in Some Patients With Hereditary Hemorrhagic Telangiectasia?
Claire L Shovlin, Clare Gilson, Mark Busbridge, Dilip Patel, Chenyang Shi

Laryngoscope· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of hepcidin response to holotransferrin in novel recombinant TfR1 HepG2 cells.
Kosha Mehta, Mark Busbridge, Derek Renshaw, Robert W Evans, Sebastien Farnaud

Blood Cells Mol Dis· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease.
Martin Wagner, Damien R Ashby, Caroline Kurtz, Ahsan Alam, Mark Busbridge

PLoS One· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of hepcidin response to holotransferrin treatment in CHO TRVb-1 cells.
Kosha Mehta, Pamela Greenwell, Derek Renshaw, Mark Busbridge, Mitla Garcia

Blood Cells Mol Dis· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Intravenous Iron on Aerobic Capacity and Iron Metabolism in Elite Athletes.
Richard J Burden, Noel Pollock, Gregory P Whyte, Toby Richards, Brian Moore, Mark Busbridge

Med Sci Sports Exerc· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron homeostasis and pulmonary hypertension: iron deficiency leads to pulmonary vascular remodeling in the rat.
Emanuele Cotroneo, Ali Ashek, Lei Wang, John Wharton, Olivier Dubois, Mark Busbridge

Circ Res· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating pancreatic polypeptide concentrations predict visceral and liver fat content.
Amir H Sam, Michelle L Sleeth, E Louise Thomas, Nurhafzan A Ismail, Norlida Mat Daud, Mark Busbridge

J Clin Endocrinol Metab· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute and chronic effects of kisspeptin-54 administration on GH, prolactin and TSH secretion in healthy women.
Channa N Jayasena, Alexander N Comninos, Shakunthala Narayanaswamy, Sanjana Bhalla, Ali Abbara, Mark Busbridge

Clin Endocrinol (Oxf)· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiopulmonary exercise testing demonstrates maintenance of exercise capacity in patients with hypoxemia and pulmonary arteriovenous malformations.
Luke S G E Howard, Vatshalan Santhirapala, Kevin Murphy, Bhashkar Mukherjee, Mark Busbridge

Chest· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemorrhage-adjusted iron requirements, hematinics and hepcidin define hereditary hemorrhagic telangiectasia as a model of hemorrhagic iron deficiency.
Helen Finnamore, James Le Couteur, Mary Hickson, Mark Busbridge, Kevin Whelan

PLoS One· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal iron fortification of maternal diet during pregnancy and nursing for investigating and preventing iron deficiency in young rhesus monkeys.
Christopher L Coe, Gabriele R Lubach, Mark Busbridge, Richard S Chapman

Res Vet Sci· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissociation of ferritin and hepcidin in a case of adult-onset Still's disease.
Hannah Tharmalingam, Damien R Ashby, Mark Busbridge, Candice Roufosse, Tom D Cairns

Int J Hematol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
Arvind Sangwaiya, Vijay Manglam, Mark Busbridge, Mark Thursz, Jayantha Arnold

Eur J Gastroenterol Hepatol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights.
Christopher J Rhodes, Luke S Howard, Mark Busbridge, Damien Ashby, Eumorfia Kondili

J Am Coll Cardiol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexplained iron deficiency in idiopathic and heritable pulmonary arterial hypertension.
Elaine Soon, Carmen M Treacy, Mark R Toshner, Robert MacKenzie-Ross, Vijay Manglam, Mark Busbridge

Thorax· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepcidin levels in hereditary hyperferritinemia: Insights into the iron-sensing mechanism in hepatocytes.
Jayantha Arnold, Arvind Sangwaiya, Vijay Manglam, Mark Thursz, Caroline Beaumont, Mark Busbridge

World J Gastroenterol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of hepcidin-25 in biological fluids: bile, ascitic and pleural fluids.
Jayantha Arnold, Arvind Sangwaiya, Vijay Manglam, Frank Geoghegan, Mark Thursz, Mark Busbridge

World J Gastroenterol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin.
Damien R Ashby, Daniel P Gale, Mark Busbridge, Kevin G Murphy, Neill D Duncan

Haematologica· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization.
Joyce J C Kroot, Erwin H J M Kemna, Sukhvinder S Bansal, Mark Busbridge, Natascia Campostrini

Haematologica· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment.
Damien R Ashby, Heather E Ford, Katie J Wynne, Alison M Wren, Kevin G Murphy, Mark Busbridge

Kidney Int· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasis.
Jayantha Arnold, Arvind Sangwaiya, Bharati Bhatkal, Frank Geoghegan, Mark Busbridge

Eur J Gastroenterol Hepatol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis